Abdel-Rahman MS, Hetland LB, Couri D. 1976 Toxicity and metabolism of methyl n-butyl ketone. Am Ind Hyg Assoc J 37:95-102.

Abdo KM, Graham DG, Timmons PR, Abou-Donia MB. 1982 Neurotoxicity of continuous (90 days) inhalation of technical grade methyl butyl ketone in hens. J Toxicol Environ Health 9:199-215.

Abou-Donia MB, Makkawy H-AM, Graham DG. 1982 The relative neurotoxicities of n-hexane, methyl n-butyl ketone, 2,5-hexanediol and 2,5-hexanedione following oral or intraperitoneal administration in hens. Toxicol Appl Pharmacol 62:369-389.

ACGIH. 2000 Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Limits. American Conference of Governmental Industrial Hygienists.

Allen N, Mendell JR, Billmaier DJ, Fontaine RE, O'Neill J. 1975 Toxic neuropathy due to methyl n-butyl ketone. An industrial outbreak. Arch Neurol 32:209-218.

Amoore JE, Hautala E. 1983 Odor as an aid to chemical safety: odor thresholds compared with threshold limit values and volatilities for 214 industrial chemicals in air and water dilution. J Appl Toxicol 3 (6):272-290.

Anthony DC, Boekelheide K, Anderson CW, Graham DG. 1983 The effects of 3,4-dimethyl substitution on the neurotoxicity of 2,5-hexanedione. II. Dimethyl substitution accelerates pyrrole formation and protein crosslinking. Toxicol Appl Pharmacol 71:372-382.

Bäckström B, Shibata E, Nylen P, Collins PV. 1998 2,5-Hexanedione concentrations and morphological changes within the eye of the albino rat. Arch Toxicol 72:597-600.

Billmaier D, Yee HT, Allen N, Craft B, Williams N, Epstein S, Fontaine R. 1974 Peripheral neuropathy in a coated fabrics plant. Occup Med 16 (10):665-671.

Bos PMJ, de Mik G, Bragt PC. 1991 Critical review of the toxicity of methyl n-butyl ketone: risk from occupational exposure. Am J Ind Med 20:175-194.

Cardona A, Marhuenda D, Marti J, Brugnone F, Roel J, Perbellini L. 1993 Biological monitoring of occupational exposure to n-hexane by measurement of urinary 2,5-hexanedione. Int Arch Occup Environ Health 65:71-74.

Chang YC. 1990 Patients with n-hexane induced polyneuropathy: a clinical follow up. Br J Ind Med 47:485-489.

Chang YC. 1991 An electrophysical follow up of patients with n-hexane polyneuropathy. Br J Ind Med 48:12-17.

Couri D, Hetland LB, Abdel-Rahman MS, Weiss H. 1977 The influence of inhaled ketone solvent vapors on hepatic microsomal biotransformation activities. Toxicol Appl Pharmacol 41:285-289.

Couri D, Abdel-Rahman MS, Hetland LB. 1978 Biotransformation of n-hexane and methyl n-butyl ketone in guinea pigs and mice. Am Ind Hyg Assoc J 39:295-300.

Davenport JG, Farrell DF, Sumi SM. 1976 "Giant axonal neuropathy" caused by industrial chemicals: neurofilamentous axonal masses in man. Neurology 26:919-923.

DeCaprio AP, Olajos EJ, Weber P. 1982 Covalent binding of a neurotoxic n-hexane metabolite: conversion of primary amines to substituted pyrrole adducts by 2,5-hexanedione. Toxicol Appl Pharmacol 65:440-450.

DeCaprio AP, O'Neill EA. 1985 Alterations in rat axonal cytoskeleton proteins induced by in vitro and in vivo 2,5-hexanedione exposure. Toxicol Appl Pharmacol 78:235-247.

Denkhaus W, Steldern DV, Botzenhardt U, Konietzko H. 1986 Lymphocyte subpopulations in solventexposed workers. Int Arch Occup Med Health 57:109-115.

DiVincenzo GD, Hamilton ML, Kaplan CJ, Dedinas J. 1977 Metabolic fate and disposition of 14C-labeled methyl n-butyl ketone in the rat. Toxicol Appl Pharmacol 41:547-560.

DiVincenzo GD, Hamilton ML, Kaplan CJ, Krasavage WJ, O'Donoghue JL. 1978 Studies on the respiratory uptake and excretion and the skin absorption of methyl n-butyl ketone in humans and dogs. Toxicol Appl Pharmacol 44:593-604.

Duckett S, Williams N, Francis S. 1974 Peripheral neuropathy associated with methyl n-butyl ketone. Experimentia 30:1283-1284.

Feldman RG. 1999 Occupational and Environmental Neurotoxicology. Lippincott-Raven, Philadelphia.

Genter MB, Szakal-Quinn G, Anderson CW, Anthony DC, Graham DG. 1987. Evidence that pyrrole formation is a pathogenic step in y-diketone neuropathy. Toxicol Appl Pharmacol 87:351-362.

Governa M, Calisti R, Coppa G, Tagliavento G, Colombi A, Troni W. 1987 Urinary excretion of 2,5-hexanedione and peripheral polyneuropathies in workers exposed to hexane. J Toxicol Environ Health 20:219-228.

Graham DG, Anthony DC, Boekelheide K, Maschmann NA, Richards RG, Wolfram JW, Shaw BR. 1982 Studies of the molecular pathogenesis of hexane neuropathy. II. Evidence that pyrrole derivatization of lysyl residues leads to protein crosslinking. Toxicol Appl Pharmacol 64:415-422.

Graham DG, Amarnath V, Valentine WM, Pyle SJ, Anthony DC. 1995 Pathogenetic studies of hexane and carbon disulfide neurotoxicity. Crit Rev Toxicol 25 (2):91-112.

Granvil CP, Sharkawi M, Plaa GL. 1994 Metabolic fate of methyl n-butyl ketone, methyl ethyl ketone and their metabolites in mice. Toxicol Lett 70:263-267.

Griffin JW. 1981 Hexacarbon neurotoxicity. Neurobehav Toxicol Teratol 3:437-444.

Griffin JW, Fahnestock KE, Price DL, Cork LC. 1983 Cytoskeleton disorganisation induced by local application of ß,ß'-iminodipropionitrile and 2,5-hexanedione. Ann Neurol 14:55-61.

Harbison RD, Garvey GJ. 1998 Aldehydes and ketones. In: Hamilton and Hardy's Industrial Toxicology, fifth edition. Harbison RD (editor). Mosby, St Louis.

Hewitt WR, Miyajima H, Côté MG, Plaa GL. 1980 Acute alternation of chloroform-induced hepato- and nephrotoxicity by n-hexane, methyl n-butyl ketone, and 2-5-hexanedione. Toxicol Appl Pharmacol 53:230-248.

Horimoto M, Isobe Y, Isogai Y, Tachibana M. 2000 Rat epididymal sperm motion changes induced by ethylene glycol monoethyl ether, sulfasalazine and 2,5-hexanedione. Reprod Toxicol 14 (1):55-63.

Huang C-C, Chu N-S, Cheng S-Y, Shin T-S. 1989 Biphasic recovery in n-hexane polyneuropathy. A clinical and electrophysiological study. Acta Neurol Scand 80:610-615.

IPCS. 1991 Environmental Health Criteria 122. n-Hexane. World Health Organization, International Programme on Chemical Safety, Geneva.

Iwata M, Takeuchi Y, Hisanaga N, Ono Y. 1983 A study on biological monitoring of n-hexane exposure. Int Arch Occup Environ Health 51:253-260.

Katz GV, O'Donoghue JL, Divicenzo GD, Terhaar CJ. 1980 Comparative neurotoxicty and metabolism of ethyl n-butyl ketone and methyl n-butyl ketone in rats. Toxicol Appl Pharmacol 52:153-158.

Krasavage WJ, O'Donoghue JL, Terhaar CJ. 1979 Oral chronic toxicity of methyl n-propyl ketone, methyl n-butyl ketone and hexane in rats [abstract]. Toxicol Appl Pharmacol 48 (pt 2):A205.

Krasavage WJ, O'Donoghue JL, DiVincenzo GD, Terhaar CJ. 1980 The relative neurotoxicity of methyl-n-butyl ketone, n-hexane and their metabolites. Toxicol Appl Pharmacol 52:433-441.

Kuwabara S, Nakajima M, Tsuboi Y, Hirayama K. 1993 Multifocal conduction block in n-hexane neuropathy. Muscle Nerve 16 (2):1416-1417.

Mallov JS. 1976 MBK neuropathy among spray painters. J Am Med Assoc 235 (14):1455-1457.

Mateus ML, dos Santos APM, Batoreu MC. 2000 Evidence for zinc protection against 2,5-hexanedione toxicity by co-exposure of rats to zinc chloride. J Appl Toxicol 20:211-214.

McDonough JR. 1974 Possible neuropathy from methyl n-butyl ketone [letter]. N Engl J Med 290 (2):695.

Mendell JR, Saida K, Ganasia MF, Jackson DB, Weiss H, Gardier RW, Chrisman C, Allen N, Couri D, O'Neill B, Marks B, Hetland L. 1974 Toxic polyneuropathy produced by methyl n-butyl ketone. Science 185:787-789.

Mutti A, Falzoi M, Lucertini S, Arfini G, Zignani M, Lombardi S, Franchini I. 1984 n-Hexane metabolism in occupationally exposed workers. Br J Ind Med 41:533-538.

O'Donoghue JL, Krasavage WJ, Terhaar CJ. 1978 Toxic effects of 2,5-hexanedione [abstract]. Toxicol Appl Pharmacol 45:269.

O'Donoghue JL, Krasavage WJ. 1979 Hexacarbon neuropathy: a y-diketone neuropathy? J Neuropathol Exp Neurol 38:333.

Perbellini L, Brugnone F, Faggionato G. 1981 Urinary excretion of the metabolites of n-hexane and its isomers during occupational exposure. Br J Ind Med 38:20-26.

Periago JF, Cardona A, Marhuenada D, Roel J, Villanueva M, Marti J, Luna A. 1993 Biological monitoring of occupational exposure to n-hexane by exhaled air analysis and urinalysis. Int Arch Occup Environ Health 65:275-278.

Peters MA, Hudson PM, Dixon RL. 1981 The effect totigestational exposure to methyl-n-butyl ketone has on postnatal development and behavior. Ecotoxicol Environ Safety 5:291-306.

Pezzoli G, Barbieri S, Ferrante C, Zecchinelli A, Foa V. 1989 Parkinsonism due to n-hexane exposure [letter]. Lancet 2:874.

Pezzoli G, Antonini A, Barbieri S, Canesi M, Perbellini L, Zecchinelli A, Mariani CB, Bonetti A, Leenders KL. 1995 n-Hexane-induced parkinsonism: pathogenic hypotheses. Mov Disord 10 (3):279-282.

Pilon D, Charbonneau M, Brodeur J, Plaa GL. 1986 Metabolites and ketone body production following methyl n-butyl ketone exposure as possible indices of MnBK potentiation of carbon tetrachloride hepatotoxicity. Toxicol Appl Pharmacol 85:49-59.

Plaa GL, Ayotte P. 1985 Taurolithocholate-induced intrahepatic cholestasis: potentiation by methyl isobutyl ketone and methyl n-butyl ketone in rats. Toxicol Appl Pharmacol 80:228-234.

Raitta C, Seppäläinen A-M, Huuskonen MS. 1978 n-Hexane maculopathy in industrial workers. Graefes Arch Ophthalmol 209:99-110.

Ralston WH, Hilderbrand RL, Uddin D, Andersen ME, Gardier RW. 1985 Potentiation of 2,5-hexanedione neurotoxicity by methyl ethyl ketone. Toxicol Appl Pharmacol 81:319-729.

Saida K, Mendell JR, Weiss HS. 1976 Peripheral nerve changes induced by methyl n-butyl ketone and potentiation by methyl ethyl ketone. J Neuropathol Exp Neurol 35 (3):207-225.

Saito I, Shibata E, Huang J, Hisanaga N, Ono Y, Takeuchi Y. 1991 Determination of urinary 2,5-hexanedione concentration by an improved analytical method as an index of exposure to n-hexane. Br J Ind Med 48:568-574.

Schaumburg H, Spencer PS. 1976 Degeneration in central and peripheral nervous systems produced by pure n-hexane: an experimental study. Brain 99:183-192.

Schrenk HH, Yant WP, Patty FA. 1936 Hexanone. US Public Health Report 51:624. Cited in: Topping DC, Morgott DA, David RM, O'Donoghue JL. 2001 Ketones of six to thirteen carbons. In: Patty's Toxicology, fifth edition, Volume 6. Bingham E, Cohrssen B, Powell CH (editors). John Wiley & Sons Inc, New York.

Sharkawi M, Granvil C, Faci A, Plaa GL. 1994 Pharmacodynamic and metabolic interactions between ethanol and two industrial solvents (methyl n-butyl ketone and methyl isobutyl ketone) and the principal metabolite in mice. Toxicology 94:187-195.

Shibata E, Huang J, Ono Y, Hisanaga N, Iwata M, Saito I, Takeuchi Y. 1990 Changes in urinary n-hexane metabolites by co-exposure to various concentrations of methyl ethyl ketone and fixed n-hexane levels. Arch Toxicol 64:165-168.

Smith AG, Albers JW. 1997 n-Hexane neuropathy due to rubber cement sniffing. Muscle Nerve 20:1445-1450.

Spencer PS, Schaumberg HH, 1975 Experimental neuropathy produced by 2,5-hexanedione - a major metabolite of the neurotoxic industrial solvent methyl n-butyl ketone. J Neurol Neurosurg Psychiat 38:771-775.

Spencer PS, Schaumberg HH, Raleigh RL Terhaar CJ. 1975 Nervous system degeneration produced by the industrial solvent methyl n-butyl ketone. Arch Neurol 32:219-222.

Spencer PS, Bishoff MC, Schaumburg HH. 1978 On the specific molecular configuration of neurotoxic aliphatic hexacarbon compounds causing central-peripheral distal axonopathy. Toxicol Appl Pharmacol 44:17-28.

Spencer PS, Schaumburg HH, Sabri MI, Veronesi B. 1980 The enlarging view of hexacarbon neuropathy. CRC Crit Rev Toxicol 7 (4):279-356.

Topping DC, Morgott DA, David RM, O'Donoghue JL. 1994 Ketones. In: Patty's Industrial Hygiene and Toxicology, fourth edition, Volume 2, Part C. GD Clayton, FE Clayton (editors). John Wiley and Son, Inc, New York.

Topping DC, Morgott DA, O'Donoghue JL. 2001 Ketones of six to thirteen carbons. In: Patty's Toxicology, fifth edition, Volume 6. Bingham E, Cohrssen B, Powell CH (editors). John Wiley & Sons Inc, New York.

Wickersham CW III, Fredericks EJ. 1976 Toxic polyneuropathy secondary to methyl n-butyl ketone. Conn Med 40 (5):311-312.

Vanacore N, Gasparini M, Brusa L, Meco G. 2000 A possible association between exposure to n-hexane and parkinsonism. Neurol Sci 21:49-52.

Zhao W, Misumi J, Yasui T, Aoki K, Kimura T. 1998 Effects of methyl ethyl ketone, acetone, or toluene coadministration on 2,5-hexanedione concentration in the sciatic nerve, serum, and the urine of rats. Int Arch Occup Environ Health 71 (4):236-244.

Zimmerman FK, Scheel I, Resnick MA. 1989 Induction of chromosome loss by mixtures of organic solvents including neurotoxins. Mutat Res 224:287-303.

Peripheral Neuropathy Natural Treatment Options

Peripheral Neuropathy Natural Treatment Options

This guide will help millions of people understand this condition so that they can take control of their lives and make informed decisions. The ebook covers information on a vast number of different types of neuropathy. In addition, it will be a useful resource for their families, caregivers, and health care providers.

Get My Free Ebook

Post a comment